CT Financial Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-200
Closed -$19.5K 657
2015
Q1
$19.5K Buy
+200
New +$19.5K 0.01% 393
2014
Q1
$19.5K Buy
+200
New +$19.5K 0.01% 393